四家三级保健中心的临床无肌病性皮肌炎的系统治疗。
Systemic Treatment for Clinically Amyopathic Dermatomyositis at 4 Tertiary Care Centers.
机构信息
Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Department of Dermatology, New York University Ronald O. Perelman School of Medicine, New York.
出版信息
JAMA Dermatol. 2019 Apr 1;155(4):494-496. doi: 10.1001/jamadermatol.2018.5215.
Abstract
This study investigates the use of systemic treatment for clinically amyopathic dermatomyositis using natural language queries and codes for amyopathic and hypomyopathic dermatomyositis.
摘要
本研究使用自然语言查询和无肌病性及低肌病性皮肌炎的编码来调查临床无肌病性皮肌炎的全身治疗方法。
相似文献
1
Systemic Treatment for Clinically Amyopathic Dermatomyositis at 4 Tertiary Care Centers.四家三级保健中心的临床无肌病性皮肌炎的系统治疗。
JAMA Dermatol. 2019 Apr 1;155(4):494-496. doi: 10.1001/jamadermatol.2018.5215.
2
Amyopathic dermatomyositis with plantar keratoderma responding to methotrexate therapy.对甲氨蝶呤治疗有反应的伴足底角化病的无肌病性皮肌炎。
Cutis. 2017 Aug;100(2):E20-E24.
3
Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis.每周给予低剂量甲氨蝶呤是一种有效的糖皮质激素节省剂，用于治疗皮肌炎的皮肤表现。
J Am Acad Dermatol. 1997 Jan;36(1):67-71. doi: 10.1016/s0190-9622(97)70327-x.
4
The quinacrine experience in a population of patients with cutaneous lupus erythematosus and dermatomyositis.在一群皮肤红斑狼疮和皮肌炎患者中使用阿的平的经验。
J Am Acad Dermatol. 2017 Aug;77(2):374-377. doi: 10.1016/j.jaad.2017.03.027.
5
Prognosis of adult-onset clinically amyopathic dermatomyositis treated with only topical therapy.
J Dermatol. 2017 Jul;44(7):e178-e179. doi: 10.1111/1346-8138.13822. Epub 2017 Mar 7.
6
Factors Associated With Clinical Remission of Skin Disease in Dermatomyositis.特发性炎性肌病相关皮肤疾病临床缓解的影响因素
JAMA Dermatol. 2018 Jan 1;154(1):44-51. doi: 10.1001/jamadermatol.2017.3758.
7
A comparative study of clinical characteristics, work-up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore.中美两国两家三级皮肤中心皮肌炎临床特征、检查、治疗及与恶性肿瘤的相关性比较研究
Int J Dermatol. 2013 Jul;52(7):813-9. doi: 10.1111/j.1365-4632.2011.05449.x. Epub 2012 Jul 27.
8
Linear amyopathic dermatomyositis with calcinosis cutis responsive to topical sodium thiosulfate.伴有皮肤钙质沉着的线性无肌病性皮肌炎对局部用硫代硫酸钠有反应。
Pediatr Dermatol. 2019 Jul;36(4):e102-e103. doi: 10.1111/pde.13868. Epub 2019 May 28.
9
Clinically amyopathic dermatomyositis: clinical features, response to medications and malignancy-associated risk factors in a specific tertiary-care-centre cohort.临床无肌病性皮肌炎：特定三级医疗中心队列中的临床特征、药物反应及恶性肿瘤相关危险因素
Br J Dermatol. 2016 Jan;174(1):158-64. doi: 10.1111/bjd.14227. Epub 2015 Dec 1.
10
Amyopathic dermatomyositis--an uncommon presentation of dermatomyositis.无肌病性皮肌炎——皮肌炎的一种罕见表现形式。
Isr Med Assoc J. 2007 Jun;9(6):492-3.
引用本文的文献
1
Higher Odds of Adverse Cutaneous Reactions in Patients With Dermatomyositis Treated With Hydroxychloroquine Compared With Methotrexate.与甲氨蝶呤相比，皮肌炎患者使用羟氯喹治疗出现皮肤不良反应的几率更高。
ACR Open Rheumatol. 2023 Nov;5(11):594-599. doi: 10.1002/acr2.11605. Epub 2023 Sep 24.
2
Pitfalls in the Diagnosis and Management of an Unusual Presentation of Clinically Amyopathic Dermatomyositis: A Case Report Written With the Assistance of ChatGPT.临床无肌病性皮肌炎异常表现的诊断与管理中的陷阱：一篇在ChatGPT协助下撰写的病例报告
Cureus. 2023 Jul 14;15(7):e41879. doi: 10.7759/cureus.41879. eCollection 2023 Jul.
3
Clinical pearls and promising therapies in myositis.肌炎的临床要点和有前途的治疗方法。
Expert Rev Clin Immunol. 2023 Jul-Dec;19(7):797-811. doi: 10.1080/1744666X.2023.2212162. Epub 2023 May 18.
4
Diagnosis and Management of Cutaneous Manifestations of Autoimmune Connective Tissue Diseases.自身免疫性结缔组织病皮肤表现的诊断与管理
Clin Cosmet Investig Dermatol. 2022 Oct 26;15:2285-2312. doi: 10.2147/CCID.S360801. eCollection 2022.
5
Exploring Dermatomyositis through an Interdisciplinary Lens: Pearls from Dermatology and Rheumatology.从跨学科视角探索皮肌炎：皮肤科与风湿病学的经验之谈
Int J Womens Dermatol. 2021 Sep 24;7(5Part A):576-582. doi: 10.1016/j.ijwd.2021.09.007. eCollection 2021 Dec.
6
Clinical Characteristics and Management of Patients With Clinical Amyopathic Dermatomyositis: A Retrospective Study of 64 Patients at a Tertiary Dermatology Department.临床无肌病性皮肌炎患者的临床特征与管理：对一家三级皮肤科64例患者的回顾性研究
Front Med (Lausanne). 2021 Dec 2;8:783416. doi: 10.3389/fmed.2021.783416. eCollection 2021.
7
[Hydroxychloroquine: An Essential Drug in Dermatology and Its Controversial Use in COVID-19].[羟氯喹：皮肤科的一种基本药物及其在 COVID-19 中的争议性应用]
Actas Dermosifiliogr. 2022 Feb;113(2):166-175. doi: 10.1016/j.ad.2021.07.005. Epub 2021 Aug 2.
8
Recent Advances in Pharmacological Treatments of Adult Dermatomyositis.成人皮肌炎的药物治疗新进展。
Curr Rheumatol Rep. 2019 Aug 31;21(10):53. doi: 10.1007/s11926-019-0850-9.
本文引用的文献
1
Treatment of clinically amyopathic dermatomyositis in adults: a systematic review.成人临床无肌病性皮肌炎的治疗：系统评价。
Br J Dermatol. 2018 Dec;179(6):1248-1255. doi: 10.1111/bjd.14726. Epub 2016 Aug 30.
2
Clinically amyopathic dermatomyositis: clinical features, response to medications and malignancy-associated risk factors in a specific tertiary-care-centre cohort.临床无肌病性皮肌炎：特定三级医疗中心队列中的临床特征、药物反应及恶性肿瘤相关危险因素
Br J Dermatol. 2016 Jan;174(1):158-64. doi: 10.1111/bjd.14227. Epub 2015 Dec 1.
3
Intravenous immunoglobulin for refractory cutaneous dermatomyositis: a retrospective analysis from an academic medical center.静脉注射免疫球蛋白治疗难治性皮肤型皮肌炎：来自一所学术医疗中心的回顾性分析
J Am Acad Dermatol. 2013 Oct;69(4):654-7. doi: 10.1016/j.jaad.2013.06.007.
4
Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota.皮肌炎及临床无肌病性皮肌炎的发病率：明尼苏达州奥姆斯特德县的一项基于人群的研究
Arch Dermatol. 2010 Jan;146(1):26-30. doi: 10.1001/archdermatol.2009.328.
5
A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.成人起病的临床无肌病性皮肌炎（无肌性皮肌炎）的系统评价：特发性炎性肌病谱系中的缺失环节
J Am Acad Dermatol. 2006 Apr;54(4):597-613. doi: 10.1016/j.jaad.2005.10.041. Epub 2006 Jan 23.
6
Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus.与皮肤型红斑狼疮患者相比，羟氯喹引起的不良皮肤反应在皮肌炎患者中更为常见。
Arch Dermatol. 2002 Sep;138(9):1231-3; discussion 1233. doi: 10.1001/archderm.138.9.1231.
Zotero 插件